Discontinue Both Medications Immediately Without Taper
Based on psychiatry consultation ruling out serotonin syndrome and the patient's clinical presentation, both mirtazapine (Remeron) and escitalopram (Lexapro) can be stopped abruptly without tapering. The reactive hypoglycemia and hypertension (BP 160/90) are concerning but are not contraindications to immediate discontinuation—in fact, they may be related to the medications themselves.
Clinical Reasoning
Why Abrupt Discontinuation is Appropriate
The absence of serotonin syndrome symptoms is the key factor here. Your psychiatry consultant has already evaluated the patient and determined she does not meet criteria for serotonin syndrome. According to the Hunter Criteria, serotonin syndrome requires specific neuromuscular findings (clonus, hyperreflexia, muscle rigidity) plus autonomic instability 1. Your patient has hypertension but lacks the characteristic neuromuscular hyperactivity (tremor, clonus, hyperreflexia, muscle rigidity) and mental status changes (confusion, agitation, delirium) that define the syndrome 2.
If serotonin syndrome were present, immediate discontinuation of all serotonergic agents would be mandatory 2, 3, 4. Treatment involves discontinuing precipitating agents and supportive care with continuous cardiac monitoring 2. The mortality rate for serotonin syndrome is approximately 11%, making prompt recognition and treatment critical 1.
Addressing the Hypertension
The elevated blood pressure (160/90) is notable but does not preclude stopping these medications. In fact:
Abrupt discontinuation of SSRIs like escitalopram has been associated with new-onset hypertension 5. One case report documented sustained severe hypertension following abrupt cessation of citalopram (a closely related SSRI), attributed to adrenergic hyperactivation after removal of chronic noradrenergic neuron inhibition 5.
However, continuing the medications is not the solution. Both SSRIs and mirtazapine can affect blood pressure through various mechanisms 6. The hypertension may actually improve after discontinuation once the withdrawal period passes.
Monitor blood pressure closely during the first 24-48 hours after discontinuation and treat hypertension symptomatically if needed with standard antihypertensive agents.
Addressing the Hypoglycemia
The reactive hypoglycemia (blood sugars in low 60s) is concerning and requires monitoring, but:
Antidepressants, including both mirtazapine and SSRIs, have been associated with glucose dysregulation 7. Case reports show both hyperglycemia and hypoglycemia can occur, typically within the first month of therapy but sometimes up to 5 months 7.
Mirtazapine specifically has been linked to glucose disturbances 7. Discontinuing it may actually help stabilize glucose levels.
Ensure frequent glucose monitoring (every 4-6 hours initially) and have glucose tablets readily available. The hypoglycemia should be managed supportively with oral carbohydrates (15-20g) as needed 8.
Tapering Considerations
Neither medication requires tapering in this acute situation:
Escitalopram (Lexapro): While discontinuation syndrome can occur with SSRIs (characterized by dizziness, nausea, anxiety, irritability) 2, 4, escitalopram has a relatively lower risk compared to paroxetine, fluvoxamine, or sertraline 2. The FDA label recommends gradual dose reduction when possible but acknowledges that abrupt cessation may be necessary in certain clinical situations 4.
Mirtazapine (Remeron): The FDA label does not mandate tapering 3. Your psychiatry consultant has confirmed it can be stopped without taper in this case.
Monitoring Plan
After discontinuation, monitor for:
- Withdrawal symptoms (first 24-48 hours): dizziness, nausea, anxiety, irritability, sensory disturbances 2, 4
- Blood pressure fluctuations: Check BP every 4-6 hours initially; treat hypertension if persistent or symptomatic
- Glucose levels: Check every 4-6 hours; treat hypoglycemia with 15-20g oral carbohydrates as needed 8
- Any emergence of serotonin syndrome features: Though unlikely given psychiatry evaluation, remain vigilant for mental status changes, neuromuscular hyperactivity (clonus, hyperreflexia), or worsening autonomic instability 2, 1
Critical Pitfall to Avoid
Do not confuse discontinuation syndrome with serotonin syndrome. Discontinuation syndrome presents with dizziness, nausea, anxiety, and sensory disturbances but lacks the characteristic neuromuscular findings (clonus, hyperreflexia, muscle rigidity) of serotonin syndrome 1. Your psychiatry consultant has already made this distinction.